Private Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$223K Hold
440
0.05% 113
2023
Q2
$230K Sell
440
-25
-5% -$13.5K 0.04% 123
2023
Q1
$268K Hold
465
0.04% 117
2022
Q4
$256K Sell
465
-20
-4% -$10.6K 0.04% 119
2022
Q3
$246K Sell
485
-10
-2% -$5.6K 0.04% 122
2022
Q2
$269K Hold
495
0.04% 119
2022
Q1
$292K Hold
495
0.04% 126
2021
Q4
$330K Sell
495
-62
-11% -$38.7K 0.04% 120
2021
Q3
$318K Hold
557
0.04% 118
2021
Q2
$281K Hold
557
0.04% 133
2021
Q1
$254K Sell
557
-5
-0.9% -$2.39K 0.04% 134
2020
Q4
$262K Hold
562
0.04% 127
2020
Q3
$248K Buy
+562
New +$232K 0.04% 123

Other funds holding TMO

Private Asset Management's TMO Position: Q3 2023 in Review

Private Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2023 at 440 shares worth $223K. The position accounts for 0.05% of the portfolio, ranked #113.

Private Asset Management first reported a position in TMO in Q3 2020 and has held it in 13 quarters since. The position peaked at $330K in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Private Asset Management held 440 shares of Thermo Fisher Scientific worth $223K as of Q3 2023.
  • Private Asset Management left its Thermo Fisher Scientific share count unchanged in Q3 2023.
  • Thermo Fisher Scientific made up 0.05% of Private Asset Management's portfolio in Q3 2023, its #113 holding.
  • Private Asset Management first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 13 quarters since.
  • Private Asset Management's Thermo Fisher Scientific position peaked at $330K in Q4 2021.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Private Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.